关联应用
ASCCP Management Guidelines
开发者: American Society for Colposcopy and Cervical Pathology Inc
中国
版本统计
37天18小时
最新版本上线距今
2
近1年版本更新次数
2020-06-05
全球最早版本上线日期
版本记录
版本: 2.0.1
版本更新日期
2024-10-11
ASCCP Management Guidelines
更新日志
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 2.0
版本更新日期
2024-10-10
ASCCP Management Guidelines
更新日志
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.7
版本更新日期
2022-02-24
ASCCP Management Guidelines
更新日志
Recommendation updates based on new erratum publication.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.6
版本更新日期
2021-11-25
ASCCP Management Guidelines
更新日志
Minor improvements to management recommendations and typographical errors应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.5
版本更新日期
2021-09-24
ASCCP Management Guidelines
更新日志
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.3
版本更新日期
2021-04-09
ASCCP Management Guidelines
更新日志
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.2
版本更新日期
2020-10-01
ASCCP Management Guidelines
更新日志
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.版本: 1.1
版本更新日期
2020-08-19
ASCCP Management Guidelines
更新日志
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.应用描述
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.预订版本: 1.0
版本更新日期
2020-06-05
预订转上架日期
2020-06-05
ASCCP Management Guidelines
更新日志
暂无更新日志数据
应用描述
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
微信公众号
七麦数据公众号
七麦研究院公众号
APP下载
- IOS
- Android
@2014-2022 qimai.cn，北京七麦科技股份有限公司 All Rights Reserved. 京ICP备14049953号
京公网安备 11010502041000号
